Fate Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2008 | — | $-8.4M | — |
| FY2009 | — | $-21.5M | — |
| FY2010 | — | $-37.4M | $11.2M |
| FY2011 | — | $-50.7M | $6.4M |
| FY2012 | $1.7M | $-52.8M | $9.1M |
| FY2013 | $1.8M | $50.8M | $54.0M |
| FY2014 | $18.1M | $28.3M | $49.1M |
| FY2015 | $10.7M | $38.0M | $64.8M |
| FY2016 | $2.5M | $73.2M | $88.6M |
| FY2017 | $14.8M | $77.2M | $89.0M |
| FY2018 | $12.4M | $160.5M | $190.5M |
| FY2019 | — | $244.8M | $99.8M |
| FY2020 | — | $384.4M | $167.3M |
| FY2021 | — | $678.8M | $133.6M |
| FY2022 | — | $483.9M | $61.3M |
| FY2023 | — | $368.4M | $41.9M |
| FY2024 | — | $318.7M | $36.1M |
| FY2025 | — | $207.2M | $46.6M |